InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Nandabalan Krishnan, Director. Director active across 1 company, notably BioXcel Therapeutics, Inc.. Cumulatively, 5 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €24.5m. Activity tracked since 25 June 2021. The latest transaction was disclosed on 6 April 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
60,000 shares@ US$0.410.1% of flowCommon StockSEC:0001104659-23-043694:0
34,111 shares@ US$0.410.1% of flowCommon StockSEC:0001104659-23-001945:0
27,450 shares@ US$0.410.0% of flowCommon StockSEC:0001104659-22-118836:0
473,250 shares@ US$30.828349.9% of flowCommon StockSEC:0001104659-21-086946
473,250 shares@ US$30.828339.62% mcap50.0% of flowCommon StockSEC:0001104659-21-086946:0
5 of 5 declarations
About Nandabalan Krishnan
Krishnan Nandabalan is a Board Member of BioXcel Therapeutics, Inc. He brings expertise in corporate strategy and governance. His role on the board allows him to actively participate in strategic decision-making for the company. Through his experience, he helps guide growth initiatives and strengthen BioXcel's market position.
